A patient’s perspective can lead to new insights that traditional research may overlook. Yet how may we best harness their perspective to improve patient outcomes?


In this special long-reads episode, Manal Younus elaborates on her work on patient engagement, and how their perspective impacts drug safety monitoring and pharmacovigilance. Stay tuned for their discussion after the article, which goes into detail on how healthcare providers can more effectively engage patients, how patients themselves can become more involved in drug safety monitoring, and how the patient’s voice impacted pharmacovigilance of a specific drug: valproate.

This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance news site, brought to you in audio format. Find the original article here. Subscribe by visiting the Drug Safety Matters website.

You may also like


Rethinking Medical Device Safety in a Drug-Centric World

From software updates to complex human-machine interactions, medical devices pose safety challenges that require dedicated frameworks beyond drug vigilance.

28 August 2025

How diclofenac drove vultures to the brink and unleashed a rabies crisis

How one unusual crisis highlights the need to more effectively integrate the One Health approach and ecopharmacovigilance into pharmaceutical monitoring and legislation.

20 August 2025

Strengthening healthcare systems against substandard medicines

Counterfeit drugs threaten millions worldwide, yet healthcare workers often lack training to spot fakes or report them, leaving this problem largely invisible.

01 October 2025